Interact to see
Advertisement
Advertisement
FSPHX vs HGHRX
FSPHX vs HGHRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FSPHX vs. HGHRX commentary
Feb 04, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and HGHRX is a StrongBuy.
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.28B vs. HGHRX (841M). FSPHX pays higher dividends than HGHRX: FSPHX (0.43) vs HGHRX (0.00). FSPHX was incepted earlier than HGHRX: FSPHX (45 years) vs HGHRX (19 years). HGHRX (1.63) is less costly to investors than FSPHX (0.63). HGHRX is a more actively managed with annual turnover of: 49.00 vs. FSPHX (40.00). FSPHX (0) and HGHRX (0) have matching initial minimum investment requirements. HGHRX annual gain was more profitable for investors over the last year : 4.56 vs. FSPHX (0.29). HGHRX return over 5 years is better than : -9.67 vs. FSPHX (-13.13).
| FSPHX | HGHRX | FSPHX / HGHRX | |
| Total Expense Ratio | 0.63 | 1.63 | 39% |
| Annual Report Gross Expense Ratio | 0.63 | 1.63 | 39% |
| Fund Existence | 45 years | 19 years | - |
| Gain YTD | 0.809 | -0.431 | -188% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.28B | 841M | 746% |
| Annual Yield % from dividends | 0.43 | 0.00 | - |
| Returns for 1 year | 0.29 | 4.56 | 6% |
| Returns for 3 years | 1.47 | 9.82 | 15% |
| Returns for 5 years | -13.13 | -9.67 | 136% |
| Returns for 10 years | 62.61 | 29.84 | 210% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement